Tigecycline Although 84% of the isolates were susceptible to TGC, TGC-based therapy was associated with highly significant odd ratios of 14, 28, 90-day mortalities, adverse events, and prolonged stays, among all subgroups.
← all excerpts
<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes.
1
—
—